Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.20.1
Fair Value Measurements (Tables)
9 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:
As of March 31, 2020 (In thousands)
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant 
Other
Observable 
Inputs
(Level 2)
 
Little or No Market Activity
Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Corporate debt securities
$
1,714

 
$

 
$
1,714

 
$

Money market funds and other
415,952

 
415,952

 

 

U.S. Treasury securities

 

 

 

Marketable securities:
 
 
 
 
 
 
 
Corporate debt securities
385,161

 

 
385,161

 

Municipal securities
19,683

 

 
19,683

 

Sovereign securities
6,048

 

 
6,048

 

U.S. Government agency securities
78,680

 
78,680

 

 

U.S. Treasury securities
196,975

 
179,980

 
16,995

 

Total cash equivalents and marketable securities(1)
1,104,213

 
674,612

 
429,601

 

Other current assets:
 
 
 
 
 
 
 
Derivative assets
10,558

 

 
10,558

 

Other non-current assets:
 
 
 
 
 
 
 
Executive Deferred Savings Plan
187,937

 
148,741

 
39,196

 

Total financial assets(1)
$
1,302,708

 
$
823,353

 
$
479,355

 
$

Liabilities
 
 
 
 
 
 
 
Derivative liabilities
$
(906
)
 
$

 
$
(906
)
 
$

Deferred payments
(6,600
)
 

 

 
(6,600
)
Contingent consideration payable
(16,144
)
 

 

 
(16,144
)
Total financial liabilities
$
(23,650
)
 
$

 
$
(906
)
 
$
(22,744
)
________________
(1) Excludes cash of $444.5 million held in operating accounts and time deposits of $85.8 million as of March 31, 2020.

Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:  
As of June 30, 2019 (In thousands)
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant 
Other
Observable 
Inputs
(Level 2)
 
Little or No Market Activity
Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Corporate debt securities
$
10,988

 
$

 
$
10,988

 
$

Money market funds and other
352,708

 
352,708

 

 

U.S. Government agency securities
27,994

 

 
27,994

 

U.S. Treasury securities
55,858

 

 
55,858

 

Marketable securities:
 
 
 
 
 
 
 
Corporate debt securities
422,089

 

 
422,089

 

Municipal securities
1,913

 

 
1,913

 

Sovereign securities
5,994

 

 
5,994

 

U.S. Government agency securities
131,224

 
131,224

 

 

U.S. Treasury securities
151,838

 
151,838

 

 

Total cash equivalents and marketable securities(1)
1,160,606

 
635,770

 
524,836

 

Other current assets:
 
 
 
 
 
 
 
Derivative assets
2,557

 

 
2,557

 

Other non-current assets:
 
 
 
 
 
 
 
Executive Deferred Savings Plan
207,581

 
158,021

 
49,560

 

Total financial assets(1)
$
1,370,744

 
$
793,791

 
$
576,953

 
$

Liabilities
 
 
 
 
 
 
 
Derivative liabilities
$
(3,334
)
 
$

 
$
(3,334
)
 
$

Deferred payments
(8,800
)
 

 

 
(8,800
)
Contingent consideration payable
(14,005
)
 

 

 
(14,005
)
Total financial liabilities
$
(26,139
)
 
$

 
$
(3,334
)
 
$
(22,805
)
________________
(1) Excludes cash of $479.8 million held in operating accounts and time deposits of $99.0 million as of June 30, 2019.